The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials

Domain:

healthcare

Record type:

paper

Creator:

Jer

Publisher:

Oxf

Host:

Abstract In response to provocative comments by 2 European clinicians and scientists, the World Health Organization Director General has declared that Africa will not host COVID-19 vaccine trials. Such a stance risks stigmatizing COVID-19 vaccine trials in Africa and depriving Africa of critical research. To the contrary, there is a critical need for Africa to host COVID-19 vaccine trials on public health, scientific, and ethics grounds.

Visit

doi.org

Licenses

https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

oluwagbemi/COVID-19-Vaccine-Candidate-for-South-Africa---Phase-1

Computational development of COVID-19 Vaccine Candidate for new South African COVID-19 virus variant

COVID-19 changing pandemic pattern: why sub-Sahara Africa should reassess the current response approach

<i>‘Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?’</i> A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

There is an urgent need for an improved vaccine against tuberculosis. Heterologous prime-boost immun

Communities and Clinical Trials: A Case Study from the RTS,S Malaria Vaccine Trials in Eastern Africa

When clinical trials enter human communities, two complex systems merge—creating challenges for the

“Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa

Trust is a key element of high-quality stakeholder relations, which are themselves essential for the